Therapies/Treatments

With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to weather the storm, Deni Carise, PhD, chief science officer…

Largely fueled by a surge in methamphetamine and cocaine use, as well as fentanyl, overdose deaths in the United States increased 4.6% in the United States in 2019, NIDA director Nora Volkow, MD, told attendees in a Cocaine, Meth & Stimulant Summit keynote address presented Friday.

Florida-based behavioral healthcare provider Futures Recovery Healthcare announced that it has launched a dedicated residential mental health program. Prior to the launch of the new program, Futures treated mental health disorders only in dual-diagnosis patients who were also dealing with…

In a recent study of mice, researchers from the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas found that acute sleep deprivation enhanced the rewarding properties of cocaine use and that blocking the orexin system—the neurons that regulate many body…

Recognizing the toll that the COVID-19 pandemic has taken on the mental health of college students, Caron Treatment Centers has launched a program called Semester of Support to treat primary mental health diagnoses as well as substance use disorders.

Behavioral Innovations, a Denver-based operator of applied behavior analysis therapy providers, announced on Wednesday that it has expanded in Colorado with new centers in Arvada and the Highlands Ranch area of East Littleton, bringing the company’s number of programs in the greater Denver area to…

Universal Health Services and Eleos Health, a behavioral health tech firm, this week announced the launch of a pilot program for clinical decision-support software to analyze patient experiences and treatment outcomes.

In patients with comorbid chronic pain and substance use disorders, developing protocols for continuing opioid therapy are key for patient safety, W. Clay Jackson, MD, and Arwen Podesta, MD, DFASAM, DFAPA, ABIHM, told Psych Congress 2020 attendees.

Mydecine Innovations Group announced that its subsidiary Mindleap Health is expanding its digital therapeutic offerings with three new programs. Mindleap is a digital health platform that combines telehealth services with mood, emotion and habit tracking. Its three new programs for addiction…

How can an individual in recovery stay sober when the areas of his or her brain that process decisions aren’t functioning properly, Kevin McCauley, MD, senior fellow with Meadows Behavioral Healthcare, asked NCAD attendees in his Saturday session. In other words: How can a person protect themselves…